Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review [Coronary Heart Disease]
Conclusions
Several frequently used PPIs previously thought to be safe for concomitant use with clopidogrel were associated with greater risk of adverse cardiovascular events. Although the data are observational, they highlight the need for randomized controlled trials to evaluate the safety of concomitant PPI and clopidogrel use in patients with coronary artery disease.
Source: JAHA:Journal of the American Heart Association - Category: Cardiology Authors: Sherwood, M. W., Melloni, C., Jones, W. S., Washam, J. B., Hasselblad, V., Dolor, R. J. Tags: Coronary Heart Disease Source Type: research
More News: Cardiology | Cardiovascular | Clopidogrel | Coronary Heart Disease | Esomeprazole | Heart | Heart Attack | Heart Disease | Lansoprazole | Nexium | Omeprazole | Pantoprazole | Plavix | Prevacid | Prilosec | Proton Pump Inhibitors PPIs | Protonix | Stroke | Study